PT1112005E - Composicao antioxidante contendo acetil l-carnitina e acido alfa-lipoico - Google Patents

Composicao antioxidante contendo acetil l-carnitina e acido alfa-lipoico

Info

Publication number
PT1112005E
PT1112005E PT99939612T PT99939612T PT1112005E PT 1112005 E PT1112005 E PT 1112005E PT 99939612 T PT99939612 T PT 99939612T PT 99939612 T PT99939612 T PT 99939612T PT 1112005 E PT1112005 E PT 1112005E
Authority
PT
Portugal
Prior art keywords
carnitine
alpha
lipoic acid
antioxidant containing
containing acetyl
Prior art date
Application number
PT99939612T
Other languages
English (en)
Portuguese (pt)
Inventor
Claudio Cavazza
Original Assignee
Sigma Tau Healthscience Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11406116&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT1112005(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sigma Tau Healthscience Spa filed Critical Sigma Tau Healthscience Spa
Publication of PT1112005E publication Critical patent/PT1112005E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/385—Heterocyclic compounds having sulfur as a ring hetero atom having two or more sulfur atoms in the same ring
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Vascular Medicine (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)
PT99939612T 1998-09-01 1999-08-19 Composicao antioxidante contendo acetil l-carnitina e acido alfa-lipoico PT1112005E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT1998RM000566A IT1302307B1 (it) 1998-09-01 1998-09-01 Composizione ad attivita' antiossidante ed atta a migliorarel'utilizzazione metabolica del glucosio, comprendente acetil

Publications (1)

Publication Number Publication Date
PT1112005E true PT1112005E (pt) 2003-03-31

Family

ID=11406116

Family Applications (1)

Application Number Title Priority Date Filing Date
PT99939612T PT1112005E (pt) 1998-09-01 1999-08-19 Composicao antioxidante contendo acetil l-carnitina e acido alfa-lipoico

Country Status (28)

Country Link
US (1) US6365622B1 (enExample)
EP (1) EP1112005B2 (enExample)
JP (1) JP4361215B2 (enExample)
KR (1) KR20010079699A (enExample)
CN (1) CN1315835A (enExample)
AR (1) AR022076A1 (enExample)
AT (1) ATE228312T1 (enExample)
AU (1) AU773424B2 (enExample)
BR (1) BR9913288A (enExample)
CA (1) CA2341973C (enExample)
CZ (1) CZ2001541A3 (enExample)
DE (1) DE69904208T3 (enExample)
DK (1) DK1112005T4 (enExample)
EE (1) EE200100113A (enExample)
ES (1) ES2188214T5 (enExample)
HK (1) HK1039730A1 (enExample)
HU (1) HU229165B1 (enExample)
IL (1) IL141435A0 (enExample)
IS (1) IS5850A (enExample)
IT (1) IT1302307B1 (enExample)
MA (1) MA25284A1 (enExample)
NO (1) NO20010954L (enExample)
PL (1) PL212737B1 (enExample)
PT (1) PT1112005E (enExample)
SK (1) SK2632001A3 (enExample)
TN (1) TNSN99163A1 (enExample)
TR (1) TR200100610T2 (enExample)
WO (1) WO2000011968A1 (enExample)

Families Citing this family (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6479069B1 (en) 1999-09-23 2002-11-12 Juvenon, Inc. Nutritional supplement for increased energy and stamina
US6562869B1 (en) 1999-09-23 2003-05-13 Juvenon, Inc. Nutritional supplement for increased energy and stamina
US6335361B1 (en) * 1999-11-03 2002-01-01 Juvenon Inc. Method of treating benign forgetfulness
US6664287B2 (en) * 2000-03-15 2003-12-16 Bethesda Pharmaceuticals, Inc. Antioxidants
DE10036797A1 (de) * 2000-07-28 2002-02-07 Beiersdorf Ag Verwendung von Kombinationen mit einem Gehalt an Carnitinen
US8669282B2 (en) 2000-10-31 2014-03-11 Hill's Pet Nutrition, Inc. Companion animal compositions including lipoic acid and methods of use thereof
US20020076470A1 (en) * 2000-10-31 2002-06-20 Colgate-Palmolive Company Composition and method
JP2010142237A (ja) * 2000-10-31 2010-07-01 Colgate Palmolive Co 組成物及び方法
AU2002232616A1 (en) * 2000-10-31 2002-06-11 Colgate-Palmolive Company Compositions containing an antioxidant such as alpha lipoic acid, carnitine, vitamin C or vitamin E for preventing or inhibiting loss of cognitive function
US6555573B2 (en) 2000-12-21 2003-04-29 The Quigley Corporation Method and composition for the topical treatment of diabetic neuropathy
EA006429B1 (ru) * 2001-03-09 2005-12-29 Сосьете Де Продюи Нестле С.А. Композиция для предупреждения или восстановления возрастных функциональных дефицитов у млекопитающих и способ ее применения
SE0102380D0 (sv) * 2001-07-02 2001-07-02 Macronova Ab Kräm för behandling av åldersförändringar i huden hos människa
US6923960B2 (en) 2001-10-03 2005-08-02 Vsl Pharmaceuticals Inc. Antioxidant combination composition and use thereof
WO2003053336A2 (en) * 2001-12-19 2003-07-03 The Quigley Corporation Methods for the treatment of peripheral neural and vascular ailments
US20060127505A1 (en) * 2002-01-16 2006-06-15 David Haines Anti-inflammatory formulations
WO2003072052A2 (en) * 2002-02-22 2003-09-04 Albany College Of Pharmacy Methods and compounds useful in inhibiting oxidative and/or free radical damage and in the treatment and prevention of disease
US20040132821A1 (en) * 2002-10-11 2004-07-08 Roberto Crea Therapeutic combination of carnitine and antioxidant polyphenols
US7083813B2 (en) 2002-11-06 2006-08-01 The Quigley Corporation Methods for the treatment of peripheral neural and vascular ailments
ITRM20020620A1 (it) * 2002-12-13 2004-06-14 Sigma Tau Ind Farmaceuti Uso delle carnitine per la prevenzione e/o il trattamento dei disturbi causati dall'andropausa.
DE10258239A1 (de) * 2002-12-13 2004-06-24 Degussa Ag Formulierung enthaltend alpha-Liponsäure(-Derivate) als alleinigen Wirkstoff bei nichtchronischen alkoholinduzierten Intoxikationen
US20040265345A1 (en) * 2003-06-30 2004-12-30 Perricone Nicholas V. Treatment of skin damage using acetyl carnitine and lipoic acid
US7999003B2 (en) 2003-08-26 2011-08-16 Mannatech, Incorporated Antioxidant compositions and methods thereto
US20050214413A1 (en) * 2003-08-26 2005-09-29 Mannatech, Inc. Methods and compositions for modified release of nutritional supplements
EP1706146B1 (en) 2003-12-31 2013-08-21 K-Pax Pharmaceuticals, Inc. Nutrient compositions and use thereof for enhanced effectiveness of the immune system
US20050232911A1 (en) * 2004-04-19 2005-10-20 Schreiber Brian D Prevention and treatment of metabolic abnormalities associated with excess intramyocellular lipid
US8569367B2 (en) * 2004-11-16 2013-10-29 Allergan, Inc. Ophthalmic compositions and methods for treating eyes
CA2588708C (en) * 2004-11-24 2014-05-27 Hill's Pet Nutrition, Inc. Use of lipoic acid to improve immune response by increased natural killer cell activity
US20090176864A1 (en) * 2004-11-24 2009-07-09 Hill's Pet Nutrition, Inc. Methods For Improving Hepatic and Immune Function In An Animal
DK1817058T3 (en) * 2004-11-24 2015-12-07 Hills Pet Nutrition Inc COMPOSITION FOR USE FOR IMPROVING THE hepatic clearance xenobiotics WITH AN ANIMAL
AU2005322015B2 (en) 2004-12-29 2010-02-25 Hill's Pet Nutrition, Inc. Methods for inhibiting a decline in learning and/or memory in animals
US8148325B2 (en) * 2004-12-30 2012-04-03 Hill's Pet Nutrition, Inc. Methods for enhancing the quality of life of a senior animal
US8252742B2 (en) 2004-12-30 2012-08-28 Hill's Pet Nutrition, Inc. Methods for enhancing the quality of life of a senior animal
JP5685362B2 (ja) * 2005-04-26 2015-03-18 シグマ−タウ・インドゥストリエ・ファルマチェウチケ・リウニテ・ソシエタ・ペル・アチオニＳｉｇｍａ−Ｔａｕ Ｉｎｄｕｓｔｒｉｅ Ｆａｒｍａｃｅｕｔｉｃｈｅ Ｒｉｕｎｉｔｅ Ｓｏｃｉｅｔａ Ｐｅｒ Ａｚｉｏｎｉ 有痛性末梢糖尿病性神経障害の予防のためのアセチルｌ−カルニチン
JP5284087B2 (ja) 2005-07-14 2013-09-11 ヒルズ・ペット・ニュートリシャン・インコーポレーテッド 動物の生命を延長するための方法
CA2664982C (en) * 2006-02-23 2015-12-29 Nou-Life Sciences, Inc. Cleavable carnitine compound
CN101045048B (zh) * 2006-03-27 2011-05-18 中国科学院上海生命科学研究院 线粒体营养素组合物的应用
CN101057857B (zh) * 2006-04-21 2011-05-18 中国科学院上海生命科学研究院 一种预防与改善帕金森氏症的组合物及其制法
KR100811110B1 (ko) * 2007-02-21 2008-03-06 주식회사 디피아이 솔루션스 수분산성 α-리포산 캡슐 조성물을 함유하는 어류의 면역력증강용 사료첨가제 및 그 사용방법.
US20080226696A1 (en) * 2007-03-15 2008-09-18 Ben Treadwell Methods of improving learning abilities of aged companion animals
WO2009020317A2 (en) * 2007-08-06 2009-02-12 Biogenics, Inc. Stabilized antioxidant particles, composition comprising the same and method for preparing the same
KR20090014568A (ko) * 2007-08-06 2009-02-11 (주)바이오제닉스 코팅된 알파리포산 입자, 이를 포함하는 조성물 및 그 제조방법
US7943163B2 (en) 2007-08-22 2011-05-17 Response Scientific, Inc. Medical food or nutritional supplement, method of manufacturing same, and method of managing diabetes
US20090054513A1 (en) * 2007-08-22 2009-02-26 Response Scientific, Inc. Method of managing blood glucose levels, insulin levels and/or insulin receptor functionality in individuals with diabetes, polycystic ovarian syndrome and/or alzheimer's disease
KR100903549B1 (ko) * 2008-07-29 2009-06-23 주식회사 카이로제닉스 균질한 결정성의 아세틸-ｌ-카르니틴과 티옥트산 칼륨염의 복합염, 이의 제조방법 및 이를 포함하는 약학적 조성물
BRPI0921679A2 (pt) * 2008-11-11 2016-02-16 Sigma Tau Ind Farmaceuti composto útil para tratar celulite
EP2389931A1 (en) * 2010-05-21 2011-11-30 Raw Materials Internatinal LLC Pharmaceutical aqueous compositions comprising lipoic acid as an antioxidant
US9040082B2 (en) 2011-06-24 2015-05-26 K-Pax Pharmaceuticals, Inc. Compositions and methods for treatment of chronic fatigue
US8957048B2 (en) 2011-10-06 2015-02-17 Allergan, Inc. Compositions for the treatment of dry eye
PT2787968T (pt) 2011-12-07 2020-06-16 Allergan Inc Administração eficaz de lípidos ao filme lacrimal humano utilizando um sistema de emulsão sensível ao sal
US9907826B2 (en) 2011-12-07 2018-03-06 Allergan, Inc. Efficient lipid delivery to human tear film using a salt-sensitive emulsion system
US20140371280A1 (en) * 2013-03-15 2014-12-18 Shinichi Okuyama Method of treating diabetic peripheral neuropathy through amendment of pre-neuronal diabetic coagulative micro-angiopathy and neuronal deficiency of mitochondrial ATP production, and through induction of neuronal regeneration
US20190290609A1 (en) * 2014-03-19 2019-09-26 Epitech Group S.P.A. Pharmaceutical composition comprising palmitoylethanolamide and l-acetylcarnitine
CA2965671A1 (en) 2014-10-24 2016-04-28 Robert Shorr Methods and compositions for the treatment of pre-diabetes, diabetes and metabolic syndrome
AU2015353701B2 (en) 2014-11-25 2021-03-25 Allergan, Inc. Stabilized omega-3 ophthalmic compositions
PL3277273T3 (pl) 2015-03-31 2020-11-02 Kolinpharma S.P.A. Kompozycja do leczenia neuropatii i/lub bólu neuropatycznego
CN107922922A (zh) * 2015-08-24 2018-04-17 维特罗利夫瑞典股份公司 培养基
US11998554B2 (en) * 2018-09-10 2024-06-04 URIACH ITALY S.r.l. Composition comprising lipoic acid and vitamin D for the prevention and the treatment of neurodegenerative diseases and peripheral neuropathies
CN111467385B (zh) * 2019-01-24 2022-05-17 深圳市华大农业应用研究院 组合物在预防或治疗神经退行性疾病中的用途
DK3773012T3 (da) * 2019-04-18 2021-09-13 Simo Rasi Sammensætning til anvendelse ved forebyggelse eller reduktion af oxidativt stress og neurodegenerative sygdomme
WO2022215085A1 (en) * 2021-04-06 2022-10-13 Celagenex Research (India) Pvt. Ltd. A synergistic composition for potentiating stabilized atp
CN112999220B (zh) * 2021-04-07 2022-12-13 中国人民解放军南部战区总医院 α-硫辛酸在作为和/或制备金属β-内酰胺酶抑制剂中的应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5668117A (en) 1991-02-22 1997-09-16 Shapiro; Howard K. Methods of treating neurological diseases and etiologically related symptomology using carbonyl trapping agents in combination with previously known medicaments
AU6482596A (en) 1995-07-03 1997-02-05 Wilson T. Crandall Transdermal and oral treatment of androgenic alopecia
IT1283967B1 (it) 1996-03-29 1998-05-07 Sigma Tau Ind Farmaceuti Uso di l-carnitina o derivati della l-carnitina ed antiossidanti nella prevenzione e trattamento di patologie derivanti da danni ossidativi
US5977162A (en) * 1996-09-16 1999-11-02 Seidman; Michael D. Therapeutic treatment for auditory function
CA2280093A1 (en) * 1997-02-04 1998-08-06 John V. Kosbab Compositions and methods for prevention and treatment of vascular degenerative diseases
IT1291113B1 (it) * 1997-03-20 1998-12-29 Sigma Tau Ind Farmaceuti Composizione nutritiva terapeutica per soggetti affetti da diabete mellito
US5916912A (en) 1997-06-16 1999-06-29 The Regents Of The University Of California Dietary composition for enhancing metabolism and alleviating oxidative stress

Also Published As

Publication number Publication date
CN1315835A (zh) 2001-10-03
CZ2001541A3 (cs) 2001-09-12
AR022076A1 (es) 2002-09-04
IS5850A (is) 2001-02-16
DK1112005T4 (da) 2010-06-14
BR9913288A (pt) 2001-05-22
DK1112005T3 (da) 2002-12-30
JP2002523435A (ja) 2002-07-30
ATE228312T1 (de) 2002-12-15
EP1112005A1 (en) 2001-07-04
ITRM980566A0 (it) 1998-09-01
WO2000011968A8 (en) 2000-05-11
AU5387199A (en) 2000-03-21
WO2000011968A1 (en) 2000-03-09
HUP0102909A2 (hu) 2002-03-28
CA2341973C (en) 2009-05-12
EP1112005B2 (en) 2010-03-24
ES2188214T5 (es) 2010-06-08
CA2341973A1 (en) 2000-03-09
PL212737B1 (pl) 2012-11-30
AU773424B2 (en) 2004-05-27
EE200100113A (et) 2002-06-17
KR20010079699A (ko) 2001-08-22
PL346318A1 (en) 2002-01-28
HK1039730A1 (zh) 2002-05-10
DE69904208D1 (de) 2003-01-09
DE69904208T2 (de) 2003-08-28
US6365622B1 (en) 2002-04-02
MA25284A1 (fr) 2001-12-31
IL141435A0 (en) 2002-03-10
ITRM980566A1 (it) 2000-03-01
EP1112005B1 (en) 2002-11-27
NO20010954D0 (no) 2001-02-26
DE69904208T3 (de) 2010-09-30
TR200100610T2 (tr) 2001-07-23
HU229165B1 (en) 2013-09-30
ES2188214T3 (es) 2003-06-16
TNSN99163A1 (fr) 2005-11-10
JP4361215B2 (ja) 2009-11-11
IT1302307B1 (it) 2000-09-05
SK2632001A3 (en) 2001-08-06
NO20010954L (no) 2001-04-25
HUP0102909A3 (en) 2002-12-28

Similar Documents

Publication Publication Date Title
PT1112005E (pt) Composicao antioxidante contendo acetil l-carnitina e acido alfa-lipoico
FI20010683L (fi) Nateglinidiä sisältävä koostumus
HUP0100819A3 (en) Aminophenoxyacetic acid derivatives as neuroprotectants and pharmaceutical compositions containing them
DE69813922D1 (de) Hydroxycarbonsäure oder Retinoid enthaltende Zusammensetzungen
IS5744A (is) Nýjar 3-arýl-própíónsýruafleiður og -hliðstæður
ATE239005T1 (de) (4-sulfonylamino)-tetrahydropyran-4-carbonsäure hydroxamiden
DE69725804D1 (de) Hydroxycarbonsäure oder Retinoid enthaltende kosmetische Zusammensetzungen
PL345730A1 (en) Phenoxyacetic acid derivatives and medicinal compositions containing the same
DK1100769T3 (da) Aminomethylcarboxylsyrederivater
NO20012265D0 (no) Dispergerbare blandinger inneholdende L-DOPA-etylester
ATE357237T1 (de) Formulierungen enthaltend cefuroxim-axetil
PL342817A1 (en) Novel derivatives of dihydroxyhexanic acid
IT1298731B1 (it) Composizioni farmaceutiche contenenti complessi di inclusione con melatonina
ID27729A (id) Komposisi-komposisi anti-enzim yang mengandung asam etilendiamin disuksinat
AU768217C (en) 2-methylpropionic acid derivatives and medicinal compositions containing the same
IL140861A0 (en) Dioxolane derivatives and processess for the preparation of (s) -2-amino-6,6- dimethoxythexanoic acid methyl ester utilizing the same
SI1112005T1 (en) Antioxidant composition comprising acetyl l-carnitine and alpha-lipoic acid
HUP0102705A3 (en) Alpha-amino acid phenyl ester derivatives and their use and pharmaceutical compositions comprising them
IT1290440B1 (it) Composizione contenente acido ialuronico e flavonoidi
AU5550200A (en) Topical composition comprising acetyl salicylic acid
FI982470A0 (fi) Vitamiineja sisältävä voidekoostumus
UA3147S (uk) Етикетка коньяку
SE9803619D0 (sv) Fatty acid formulation
UA2354S (uk) Комплект етикеток для горілки "богданів край"
TW415615U (en) Structure composition of tag